Pharma Girl Cannabis World has announced that its flagship product, HIGH LOVR, will be available for sale in Canada starting September 2025, marking a first for a cannabis product from Missouri. This product is not only entering Canada’s regulated market but is also covered by Canadian health insurance, making it a reimbursable item for patients.
HIGH LOVR is a THC oil designed for topical application, specifically targeting full-body relief, including intimate areas. Unlike many cannabis products, it does not produce a psychoactive high and is free from side effects. This product focuses on wellness, particularly for women, and aims to provide an alternative to outdated formulations and branding prevalent in the market.
The approval of HIGH LOVR signifies a noteworthy achievement for Pharma Girl, which has adhered to strict quality standards and clean formulations. Jill College, the founder and a former pharmaceutical sales professional, emphasized that this development validates the brand’s mission. “We’re proving that a little Midwest magic can not only cross borders, it can get a prescription pad behind it,” she stated.
In addition to its Canadian launch, Pharma Girl plans to expand into New York, tapping into one of the fastest-growing cannabis markets in the United States. Currently, HIGH LOVR is already stocked in several top dispensaries across Missouri, and the company is set to reach a broader audience of patients and wellness seekers.
With this approval, veterans and patients in Canada can include HIGH LOVR as part of their covered medical cannabis allowance. Pharma Girl aims for this to set a precedent in the United States, advocating for similar access to affordable wellness products.
For those interested in carrying HIGH LOVR or arranging an interview with Jill College, inquiries can be directed to jill@pharma-girl.com or by calling 314-750-5422.
English 
Spanish 
German 
Czech